At Antibody Design, we use AI neural networks to develop smartphone compatible immuno-detection assays. Having identified a valuable opportunity in digitalisation, we are currently using our platform on a novel point-of-care, rapid action tool that can aid the diagnosis and treatment of  metabolic and infectious disease. Our platform technology can be applied to a wide range of medical, environmental and agricultural use cases.